Investor Type | Firm |
Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Life Science • Oncology • Consumer |
Stages | Seed, Series A |
Investing | United States |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Assets Under Management | $2,230,000,000 |
Casdin Capital is a venture capital firm focused on disruptive businesses. The firm invests in the life sciences, biotechnology and healthcare sectors. It is based in New York, New York and was formed in 2011.